Blood transfusion is a fundamental therapy in numerous pathological conditions. Regrettably, many clinical reports describe adverse transfusion's drawbacks due to red blood cells alterations during storage. Thus, the possibility for a blood bank to ameliorate the quality of the erythrocyte concentrates units is crucial to improve clinical results and reduce transfusion adverse occurrences. Leukodepletion is a pre-storage treatment recognized to better preserve the quality of red blood cells with respect to leukoreduction. Aim of this work is to unravel the biochemical and biophysical basis that sustain the good clinical outcomes associated to the use of leukodepleted erythrocytes units. Erythrocytes concentrates were prepared as leukoreduced (n=8) and pre-storage leukodepleted (n=8) and then studied during 6 weeks in blood bank conditions. Overall, the data indicate that leukodepletion not only provide red blood cells with an appropriate amount of nutrients for a longer time but also selects red blood cells characterized by a more resilient plasma membrane fit to prolong their viability. We believe these results will stimulate new ideas to further optimize the current storage protocols.
The assessment of the higher-order structure (HOS) byNMR is apowerful methodology to characterize the structural features of biologics.Forced oxidative stress studies are used to investigate the stabilityprofile, to develop pharmaceutical formulations and analytical methods.Here, the effects of forced oxidative stress by H2O2 on the monoclonal antibody Abituzumab have been characterizedby a multianalytical approach combining NMR spectroscopy, mass spectrometry,differential scanning calorimetry, surface plasmon resonance, computationaltools, and bioassays. This integrated strategy has provided qualitativeand semiquantitative characterization of the samples and informationat residue level of the effects that oxidation has on the HOS of Abituzumab,correlating them to the loss of the biological activity.
26 May 2022 in Journal of the American Chemical Society
Multispecific biologics are an emerging class of drugs, in which antibodies and/or proteins designed to bind pharmacological targets are covalently linked or expressed as fusion proteins to increase both therapeutic efficacy and safety. Epitope mapping on the target proteins provides key information to improve the affinity and also to monitor the manufacturing process and drug stability. Solid-state NMR has been here used to identify the pattern of the residues of the programmed cell death ligand 1 (PD-LI) ectodomain that are involved in the interaction with a new multispecific biological drug. This is possible because the large size and the intrinsic flexibility of the complexes are not limiting factors for solid-state NMR.
5 February 2022 in European Journal of Pharmaceutical Sciences